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Objectives: The purpose of this study was to evaluate the difference in serum chromium, magnesium and 
zinc levels between diabetic and control groups, and to determine the correlations between these elements 
and serum glucose in patients with type 2 diabetes mellitus. 
Methods: Forty patients suffering from type 2 diabetes and 30 controls were selected randomly. The level 
of serum chromium, magnesium and zinc were measured and compared between the two groups. 
Correlations of serum Cr, Mg and Zn with serum glucose were conducted. 
Results: There was a very significant difference in some serum trace elements level between diabetic and 
control groups. Serum magnesium and zinc were significantly lower in diabetic group compared with the 
control group (P= 0.014, P < 0.0001 respectively). Negative but not significant correlations were shown 
between Cr, Mg and Zn and serum glucose. 
ConclusioN: There is trace elements metabolism disorder in patients with type 2 diabetes mellitus. 
Magnesium and zinc could be considered suitable for inclusion in a nutritional supplement for diabetes 
with significant value for the treatment of diabetics and prevention of complications. 




ل  ةة رللص لا لاا ل ا مويلرلاا لاة لا كلا تةةوت لفةفرل لةةساردلا هذه تفده :فادهلأا  ممااء ةةولا سال لا ث ولا نة ةةولا ااء دةةضةت ىد
.لدلا ة س كلا توتا ةصلوفلا هذه كلا توت  مص طلبترلاا كلقلاع ءلجاإا ،لوالجترلا طبضلا لع رجرص لهتارلقتا 
  ت لا  ت طبةةةض لع رجت ذمأ خت لرم لةةةسارء لع رجرم خهذمأ خت ملةةةضاةت ن فصرأ :لقاةطلا03  كلا تةةةوت يلمق ختا ، الوةةةصأ صأةةةش
 لج. متع رجرلل لا لاا ل ا مويلرلا ، لاة لا ، لدلا ز  
 دقف ، طبضلا لع رجتا لسرادلا لع رجت  مص ةصلوفلا هذه كلا توت فص سف لا وفت كلقاةف ء جا لمئلة حلإا  مللوتلا كةهظأ :جئلتولا
 كلقاةفص طبةةضلا لع رجرص لارلقت دةةضةرلا لع رجت  ةة رص لا لاا ل ا مويلرلا كلا تةةوت ضلفأاا ظح ل( لا وفتP = 0.014 , P = 
0.0001.لدلا ة س كلا توتا )لا لاا ل ا مويلرلا ، لاة لا( ةصلوفلا هذه كلا توت  مص لمو ع لقلاع ء جا لساردلا هذه كةهظأ لرم ،) 
كلار رم لرهللمءإ لا جاا سال لا ث ولا نة ةةةولا دةةةضةت ىدل لا لاا ل ا مويلرلا نةةةة وع لمرهأ لةةةساردلا هذه  ت صلأا :لةةةصلاألا 
.نة ولا كلفعلضت  ت لالق لاا جلافلا سف للففلا لهةثلأ لااذغت 
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INTRODUCTION 
Diabetes Mellitus (DM) is a chronic disease characterized by a disorder of the glucose metabolism 
associated with a reduced ability of tissues to respond to insulin (insulin resistance). DM causes high 
morbidity and mortality derived by chronic micro-vascular complications such as retinopathy, nephropathy, 
or neuropathy and macro-vascular complications such as ischemic cardiac problems, cerebral vascular 
accidents, peripheral vascular disorders (1). With its associated complications, diabetes was reported to be 
the fifth leading cause of death in the United States (2). DM is now one of the major health problems in 
Sudan resulting in 10% of all hospital admissions and mortality. A small population based study in 1993 of 
a sample of 1284 adult men, showed a prevalence of 3.4% of type 2 diabetes (3).  
Combination of genetic and environmental risk factors contributed to DM pathogenesis (4). The clinical 
research suggests that the homeostasis of trace elements can be disrupted by diabetes mellitus. On the other 
hand, research also suggests that early imbalances of specific elements may play an important role in 
upsetting normal glucose and insulin metabolism (5). In fact deficiency of single element or certain 
combinations of elements such as Cr, Mg, and Zn have been shown to predispose a person to glucose 
intolerance and to promote the development of diabetic complications (6). Chromium is an essential 
nutrient involved in the metabolism of glucose and lipids. Suboptimal dietary intake of Cr is associated 
with diabetes and cardiovascular diseases. It has been reported that Cr and biotin combination reduce insulin 
resistance, hyperglycemia and lipid profiles in patients with type 2 diabetes (7-8). The data showed that Cr 
decreases the levels of cytokines and oxidative stress in diabetes (9). There are also reports of decreased 
Mg among those with diabetes (10-11). A population-based study suggested that Mg intake may protect 
against the development of type 2 diabetes in a Chinese population (12). The lower Mg' levels in diabetic 
subjects could be a consequence of reduced insulin action and increased protein catabolic processes (13). 
Hypomagnesemia seems to be associated with high mortality in critically ill patients with type 2 diabetes 
(14). Evidence of Zn and associated metallothionein involvement in the pathogenesis of type 2 diabetes is 
emerging (15). Zn complexes are proposed to improve hyperglycemia and insulin resistance in type 2 DM 
animals (16). 
The purpose of this study is to compare the serum Cr, Mg, and Zn concentrations of Sudanese patients with 
type 2 diabetes and healthy controls. 
METHODS 
Study design; a cross-sectional study in type 2 diabetic Sudanese patients was carried out in Abo Agla 
Diabetes Centre in Wad Medani city– Sudan. Forty diabetic patients of age 40-70 years (30 males and 10 
females) attended the centre for regular checkup were enrolled in the study. In the controls, apparently 
healthy non diabetic 30 individuals were recruited. The criteria for the diagnosis of diabetes mellitus was a 
positive glucose tolerance test, showing fasting blood glucose >140 mg/dl (>7.8 mmol/l). The study was 
recommended by the University of Gezira ethics committee. Patients and controls were informed about the 
objectives of the study, and written approval consent was obtained. Determination of blood glucose, Cr, 
Mg, and Zn After an overnight fasting 5ml of venous blood were drawn, serum was separated for 
determination of fasting blood glucose by the enzymatic colorimetric method. Flame technique of atomic 
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absorption spectrometry (GBC 932 Plus) was used for determination of Cr, Mg and Zn concentrations in 
the serum. 
Statistical analysis The values are presented as mean ± SD. Student’s t-test was applied for data analysis. 
Correlations were used to assess the associations between the blood glucose, Cr, Mg, and Zn. P value of 
<0.05 was considered statistically significant. 
RESULTS: 
Table 1 summarizes the mean blood glucose, Cr, Mg, and Zn in diabetic patients and healthy controls. As 
expected the blood glucose was significantly higher in patients (P < 0.0001). In type 2 diabetic group, serum 
magnesium and zinc levels were found to be significantly low (P= 0.014 - < 0.0001) as compared to the 
non-diabetic group. Although chromium was also lower in patients group compared to controls, the 
difference did not reach level of significance. Our study has shown negative correlation of blood glucose 




Table 1 Levels of glucose, Cr, Mg, and Zn in diabetic patients and control subjects 





Glucose (mg/dl) 184.93± 67.55 89.80± 13.52 < 0.0001 
Cr (ng/ml) 0.20± 0.15 0.22± 0.14 > 0.05 
Mg (mg/dl) 1.22± 0.75 1.64± 0.60 0.014 
Zn (µg/dl) 147.71± 0.38 152.0± 0.18 < 0.0001 
 
Table 2 Correlations  of  serum  glucose,  Cr, Mg and  Zn  with  glucose  in  type  2  diabetic patients 
Correlation Glucose          Cr       Mg Zn 
Glucose 1 - 0.232     - 0.10 - 0.160 
P value > 0.05        > 0.05 > 0.05 
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DISCUSSION 
DM is a disease with severe complications and morbidity and needs more attention regarding 
metabolic control, since good control reduces the prevalence of complications. The minerals have 
been postulated as nutritional interventions secondary to the pharmacological approach in the 
treatment of diabetes (17). In our study the association between Cr and diabetes has not been 
established. However, the levels of magnesium and zinc decreased significantly in the sera of 
diabetic patients. The loss of these minerals might be attributed to impaired absorption and/or the 
excess excretion of these metals in urine (glycosuria) in these patients, which may induce a 
deficiency or marginal state of these minerals in blood of diabetic patients (18). Increased urinary 
excretion of minerals signifies a decline in renal function among diabetics and is often a sign of 
uncontrolled diabetes. The limited ability of the kidneys to retain minerals may be due, in part, to 
states of hyperglycemia among those with diabetes (19). Moreover, the negative correlation between 
levels of studied metals in patients with DM suggests that the imbalance in their levels tends to 
decrease the hypoglycemic action of insulin that play an important role in the pathogenesis of DM. 
Considerably deficiency of Mg and Zn has been frequently reported in DM as a contributing factor 
to the etiology of diabetic complications such as hypertension, retinopathy, and thrombosis (20). 
DM has been suggested to be the most common metabolic disorder associated with magnesium 
deficiency, having 25% to 39% prevalence (21). In both children and adults, the association between 
magnesium deficiency and insulin resistance has been observed; hypomagnesaemia per se increases 
the incidence of type 2 diabetes and could be an early predictor of complications (22-23). Several 
studies suggest possible mechanisms, whereby low serum magnesium levels may lead to 
development of type 2 diabetes. Magnesium can be a limiting factor in carbohydrate metabolism 
since many of the enzymes in this process require magnesium as a cofactor. A strong relationship 
between magnesium and insulin action has been reported, Mg may modulate the insulin signal 
transduction pathway, or may affect the hormone receptor affinity (24). Furthermore, experimental 
studies suggest that the high magnesium intake is associated with lower concentrations of certain 
markers of systemic inflammation and endothelial dysfunction such as C-reactive protein and 
interleukin-6 (25). In alloxan-diabetic rats, magnesium could exert cardioprotective effect through 
reduced plasma total cholesterol, triglyceride, and oxidative stress markers (26).  
Epidemiological studies have demonstrated that exposure to low concentrations of Zn in drinking 
water is associated with an increase in type 1 diabetes (27-28). Zn supplementation ameliorates 
glycemic control and prevents renal pathological changes in genetically modified mouse models of 
type 2 diabetes (29). Recently, a role for zinc in improving peripheral insulin sensitivity has been 
suggested as it can potentiate insulin-stimulated glucose transport (30). Intriguingly, the link 
between zinc, diabetes and islet dysfunction has recently been demonstrated by genomewide 
association studies that identified an islet cell membrane zinc transporter, ZnT8, as one of the risk 
loci for type 2 diabetes. In a similar approach, polymorphisms in the zinc-buffering proteins 
metallothioneins have been associated to type 2 diabetes (31). Zinc–metallothionein complexes 
provide cytoprotection against free radicals and oxidative stress β-cells (32).  
We conclude that magnesium and zinc levels were significantly affected in Type 2 diabetic patients. 
Deficiency of Mg and Zn may reduce insulin sensitivity and may increase risk of secondary 
complications. Our findings may become an alternative approach to be used clinically for diabetic 
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patients to prevent their diabetic complications. 
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